Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence

Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology advances in practice 2022, Vol.6 (1), p.rkac009-rkac009
Hauptverfasser: Lever, Elliott, Colquhoun, Matthew, Flora, Kalveer, El-Ghazali, Shawki, Baslas, Rohit, Suleman, Yasir, Wieckowski, Amy, Farah, Ziad, Hamdulay, Shahir, Isaacs, Anthony, Mukherjee, Jaita, Pazos, Francis, Penn, Henry, Machado, Pedro M
Format: Artikel
Sprache:eng
Schlagworte:
Letter to the Editor (Other)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page rkac009
container_issue 1
container_start_page rkac009
container_title Rheumatology advances in practice
container_volume 6
creator Lever, Elliott
Colquhoun, Matthew
Flora, Kalveer
El-Ghazali, Shawki
Baslas, Rohit
Suleman, Yasir
Wieckowski, Amy
Farah, Ziad
Hamdulay, Shahir
Isaacs, Anthony
Mukherjee, Jaita
Pazos, Francis
Penn, Henry
Machado, Pedro M
description
doi_str_mv 10.1093/rap/rkac009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8947784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rap/rkac009</oup_id><sourcerecordid>2645472189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-3a243c8d510b7d10b68d1af00c914a31a77cf0acbf6073f8fbe3cd17db51fcc23</originalsourceid><addsrcrecordid>eNp9kU1Lw0AQhhdRbKk9eZecRJDYnWzSTTwIJX4VCoXW9rpsNrttNMnG3aTYf2-0VerFy8zAPLzz8SJ0DvgGcEQGhlcD88YFxtER6noB-C5QGhwf1B3Ut_YVY-zhCBOAU9QhAQkwhbCLFrOsbj6ygidOVjpmLZuC1zrXq-2tY7NylUtXyLI20pmPZnM31kvXa0klRZ3p0uFl6sTT5fjehcipjNzwXJZCnqETxXMr-_vcQ4vHh5f42Z1Mn8bxaOIKH7zaJdzziQjTAHBC0zYMwxS4wlhE4HMCnFKhMBeJGmJKVKgSSUQKNE0CUEJ4pIfudrpVkxQy_d6U56wy7UFmyzTP2N9Oma3ZSm9YGPmUhn4rcLUXMPq9kbZmRWaFzHNeSt1Y5g39wKcehFGLXu9QYbS1RqrfMYDZlxes9YLtvWjpi8PNftmfz7fA5Q7QTfWv0icodZOW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645472189</pqid></control><display><type>article</type><title>Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lever, Elliott ; Colquhoun, Matthew ; Flora, Kalveer ; El-Ghazali, Shawki ; Baslas, Rohit ; Suleman, Yasir ; Wieckowski, Amy ; Farah, Ziad ; Hamdulay, Shahir ; Isaacs, Anthony ; Mukherjee, Jaita ; Pazos, Francis ; Penn, Henry ; Machado, Pedro M</creator><creatorcontrib>Lever, Elliott ; Colquhoun, Matthew ; Flora, Kalveer ; El-Ghazali, Shawki ; Baslas, Rohit ; Suleman, Yasir ; Wieckowski, Amy ; Farah, Ziad ; Hamdulay, Shahir ; Isaacs, Anthony ; Mukherjee, Jaita ; Pazos, Francis ; Penn, Henry ; Machado, Pedro M</creatorcontrib><identifier>ISSN: 2514-1775</identifier><identifier>EISSN: 2514-1775</identifier><identifier>DOI: 10.1093/rap/rkac009</identifier><identifier>PMID: 35350718</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Letter to the Editor (Other)</subject><ispartof>Rheumatology advances in practice, 2022, Vol.6 (1), p.rkac009-rkac009</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-3a243c8d510b7d10b68d1af00c914a31a77cf0acbf6073f8fbe3cd17db51fcc23</citedby><cites>FETCH-LOGICAL-c412t-3a243c8d510b7d10b68d1af00c914a31a77cf0acbf6073f8fbe3cd17db51fcc23</cites><orcidid>0000-0002-8411-7972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947784/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947784/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1604,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35350718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lever, Elliott</creatorcontrib><creatorcontrib>Colquhoun, Matthew</creatorcontrib><creatorcontrib>Flora, Kalveer</creatorcontrib><creatorcontrib>El-Ghazali, Shawki</creatorcontrib><creatorcontrib>Baslas, Rohit</creatorcontrib><creatorcontrib>Suleman, Yasir</creatorcontrib><creatorcontrib>Wieckowski, Amy</creatorcontrib><creatorcontrib>Farah, Ziad</creatorcontrib><creatorcontrib>Hamdulay, Shahir</creatorcontrib><creatorcontrib>Isaacs, Anthony</creatorcontrib><creatorcontrib>Mukherjee, Jaita</creatorcontrib><creatorcontrib>Pazos, Francis</creatorcontrib><creatorcontrib>Penn, Henry</creatorcontrib><creatorcontrib>Machado, Pedro M</creatorcontrib><title>Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence</title><title>Rheumatology advances in practice</title><addtitle>Rheumatol Adv Pract</addtitle><subject>Letter to the Editor (Other)</subject><issn>2514-1775</issn><issn>2514-1775</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kU1Lw0AQhhdRbKk9eZecRJDYnWzSTTwIJX4VCoXW9rpsNrttNMnG3aTYf2-0VerFy8zAPLzz8SJ0DvgGcEQGhlcD88YFxtER6noB-C5QGhwf1B3Ut_YVY-zhCBOAU9QhAQkwhbCLFrOsbj6ygidOVjpmLZuC1zrXq-2tY7NylUtXyLI20pmPZnM31kvXa0klRZ3p0uFl6sTT5fjehcipjNzwXJZCnqETxXMr-_vcQ4vHh5f42Z1Mn8bxaOIKH7zaJdzziQjTAHBC0zYMwxS4wlhE4HMCnFKhMBeJGmJKVKgSSUQKNE0CUEJ4pIfudrpVkxQy_d6U56wy7UFmyzTP2N9Oma3ZSm9YGPmUhn4rcLUXMPq9kbZmRWaFzHNeSt1Y5g39wKcehFGLXu9QYbS1RqrfMYDZlxes9YLtvWjpi8PNftmfz7fA5Q7QTfWv0icodZOW</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Lever, Elliott</creator><creator>Colquhoun, Matthew</creator><creator>Flora, Kalveer</creator><creator>El-Ghazali, Shawki</creator><creator>Baslas, Rohit</creator><creator>Suleman, Yasir</creator><creator>Wieckowski, Amy</creator><creator>Farah, Ziad</creator><creator>Hamdulay, Shahir</creator><creator>Isaacs, Anthony</creator><creator>Mukherjee, Jaita</creator><creator>Pazos, Francis</creator><creator>Penn, Henry</creator><creator>Machado, Pedro M</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8411-7972</orcidid></search><sort><creationdate>2022</creationdate><title>Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence</title><author>Lever, Elliott ; Colquhoun, Matthew ; Flora, Kalveer ; El-Ghazali, Shawki ; Baslas, Rohit ; Suleman, Yasir ; Wieckowski, Amy ; Farah, Ziad ; Hamdulay, Shahir ; Isaacs, Anthony ; Mukherjee, Jaita ; Pazos, Francis ; Penn, Henry ; Machado, Pedro M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-3a243c8d510b7d10b68d1af00c914a31a77cf0acbf6073f8fbe3cd17db51fcc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Letter to the Editor (Other)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lever, Elliott</creatorcontrib><creatorcontrib>Colquhoun, Matthew</creatorcontrib><creatorcontrib>Flora, Kalveer</creatorcontrib><creatorcontrib>El-Ghazali, Shawki</creatorcontrib><creatorcontrib>Baslas, Rohit</creatorcontrib><creatorcontrib>Suleman, Yasir</creatorcontrib><creatorcontrib>Wieckowski, Amy</creatorcontrib><creatorcontrib>Farah, Ziad</creatorcontrib><creatorcontrib>Hamdulay, Shahir</creatorcontrib><creatorcontrib>Isaacs, Anthony</creatorcontrib><creatorcontrib>Mukherjee, Jaita</creatorcontrib><creatorcontrib>Pazos, Francis</creatorcontrib><creatorcontrib>Penn, Henry</creatorcontrib><creatorcontrib>Machado, Pedro M</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Rheumatology advances in practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lever, Elliott</au><au>Colquhoun, Matthew</au><au>Flora, Kalveer</au><au>El-Ghazali, Shawki</au><au>Baslas, Rohit</au><au>Suleman, Yasir</au><au>Wieckowski, Amy</au><au>Farah, Ziad</au><au>Hamdulay, Shahir</au><au>Isaacs, Anthony</au><au>Mukherjee, Jaita</au><au>Pazos, Francis</au><au>Penn, Henry</au><au>Machado, Pedro M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence</atitle><jtitle>Rheumatology advances in practice</jtitle><addtitle>Rheumatol Adv Pract</addtitle><date>2022</date><risdate>2022</risdate><volume>6</volume><issue>1</issue><spage>rkac009</spage><epage>rkac009</epage><pages>rkac009-rkac009</pages><issn>2514-1775</issn><eissn>2514-1775</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>35350718</pmid><doi>10.1093/rap/rkac009</doi><orcidid>https://orcid.org/0000-0002-8411-7972</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2514-1775
ispartof Rheumatology advances in practice, 2022, Vol.6 (1), p.rkac009-rkac009
issn 2514-1775
2514-1775
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8947784
source DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Letter to the Editor (Other)
title Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A01%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rituximab%20in%20rheumatology:%20single-centre%20SARS-CoV-2%20infection%20and%20COVID-19%20prevalence&rft.jtitle=Rheumatology%20advances%20in%20practice&rft.au=Lever,%20Elliott&rft.date=2022&rft.volume=6&rft.issue=1&rft.spage=rkac009&rft.epage=rkac009&rft.pages=rkac009-rkac009&rft.issn=2514-1775&rft.eissn=2514-1775&rft_id=info:doi/10.1093/rap/rkac009&rft_dat=%3Cproquest_pubme%3E2645472189%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2645472189&rft_id=info:pmid/35350718&rft_oup_id=10.1093/rap/rkac009&rfr_iscdi=true